We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
AstraZeneca partnered with insitro in a $40 million upfront agreement to use AI-driven Virtual Human technology in research into liver and heart diseases. A laboratory liver character represents the search for new treatments.